Photosensitivity

New England Journal of Medicine

Volumn 350, Issue 11, 2004, Pages 1111-1117

  Morison, Warwick L ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Johns Hopkins Green Spring   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIHISTAMINIC AGENT; ANTIMALARIAL AGENT; BETA CAROTENE; CHLOROQUINE; CORTICOSTEROID; DEMECLOCYCLINE; DOXYCYCLINE; FLUOCINONIDE; LOMEFLOXACIN; MINOCYCLINE; NALIDIXIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; QUINIDINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; SUNSCREEN; TETRACYCLINE DERIVATIVE; THIAZIDE DIURETIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL FEATURE; CLINICAL TRIAL; DESENSITIZATION; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DRUG HYPERSENSITIVITY; HUMAN; PATHOGENESIS; PHOTOALLERGY; PHOTOSENSITIVITY DISORDER; PHOTOTHERAPY; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; RASH; REVIEW; SEX RATIO; SKIN LUPUS ERYTHEMATOSUS; SOLAR URTICARIA; SUNLIGHT; ACUTE DISEASE; ADULT; CHRONIC DISEASE; FEMALE; MALE;

ACUTE DISEASE; ADULT; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; PHOTOSENSITIVITY DISORDERS;

EID: 1542347819     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMcp022558     Document Type: Review

References (25)

1. Morison WL, Stern RS. Polymorphous light eruption: a common reaction uncommonly recognized. Acta Derm Venereol 1982; 62:237-40.
2. Ros AM, Wennersten G. Current aspects of polymorphous light eruptions in Sweden. Photodermatology 1986;3:298-302.
3. Pao C, Norris PG, Corbett M, Hawk JLM. Polymorphic light eruption: prevalence in Australia and England. Br J Dermatol 1994; 130:62-4.
4. Hasan T, Ranki A, Jansen CT, Karvonen J. Disease associations in polymorphous light eruption: a long-term follow-up study of 94 patients. Arch Dermatol 1998;134: 1081-5.
5. Elpern Dj, Morison WL, Hood AR Papulovesicular light eruption: a defined subset of polymorphous light eruption. Arch Dermatol 1985;121:1286-8.
6. Hood AF, Elpern DJ, Morison WL. Histopathologic findings in papulovesicular light eruption. J Curan Pathol 1986;13:13-21.
7. Proby CM, Baker CS, Morton O, Hawk JLM. New broad-spectrum sunscreen for polymorphic light eruption. Lancet 1993; 341:1347-8.
8. Gschnait F, Honigsmann H, Brenner W, Fritsch P, WolffK. Induction of UV light tolerance by PUVA in patients with polymorphous light eruption. Br J Dermatol 1978; 99:293-5.
9. Parrish JA, Le Vine MJ, Morison WL, Gonzalez E, Fitzpatrick TB. Comparison of PUVA and beta-carotene in the treatment of polymorphous light eruption. Br J Dermatol 1979;100:187-91.
10. Murphy GM, Logan RA, Lovell CR, Morris RW, Hawk JLM, Magnus IA. Prophylactic PUVA and UVB therapy in polymorphic light eruption - a controlled trial. Br J Dermatol 1987;116:531-8.
11. Bilsland D, George SA, Gibbs NK, Aitchison T, Johnson BE, Ferguson J. A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption. Br J Dermatol 1993;129:708-12.
12. Morison WL, Momtaz K, Mosher DB, Parrish JA. UV-B phototherapy in the prophylaxis of polymorphous light eruption. Br J Dermatol 1982;106:231-3.
13. Corbett MF, Hawk JLM, Herxheimer A, Magnus IA. Controlled therapeutic trials in polymorphic light eruption. Br J Dermatol 1982;107:571-81.
14. Patel DC, Bellaney GJ, Seed PT, McGregor JM, Hawk JLM. Efficacy of short-course oral prednisolone in polymorphic light eruption: a randomized controlled trial. Br J Dermatol 2000;143:828-31.
15. Provost TT, Watson R, Simmons-O'Brien E. Significance of the anti-Ro (SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease. J Am Acad Dermatol 1996;35:147-69.
16. Ferguson J. Photosensitivity due to drugs. Photodermatol Photoimmunol Photomed 2002;18:262-9.
17. Levine JI. Medications that increase sensitivity to light: a 1990 listing. Washington, D.C.: Government Printing Office, 1991. (HHS publication FDA 91-8280.)
18. Ferguson J. Fluoroquinolone photosensitization: a review of clinical and laboratory studies. Photochem Photobiol 1995;62: 954-8.
19. Lowe NJ, Fakouhi TD, Stern RS, Bourget T, Roniker B, Swabb EA. Photoreactions with a fluoroquinolone antimicrobial: evening versus morning dosing. Clin Pharmacol Ther 1994;56:587-91.
20. Lim HW, Morison WL, Kamide R, Buchness MR, Harris R, Soter NA. Chronic actinic dermatitis: an analysis of 51 patients evaluated in the United States and Japan. Arch Dermatol 1994;130:1284-9.
21. Norris PG, Hawk JLM. Chronic actinic dermatitis: a unifying concept. Arch Dermatol 1990;126:376-8.
22. Roelandts R. Chronic actinic dermatitis. J Am Acad Dermatol 1993;28:240-9.
23. Robinson HN, Morison WL, Hood AF. Thiazide diuretic therapy and chronic photosensitivity. Arch Dermatol 1985;121:522-4.
24. Leigh IM, Hawk JLM. Treatment of chronic actinic dermatitis with azathioprine. Br J Dermatol 1984;110:691-5.
25. Duschet P, Schwarz T, Oppolzer G, Gschnait F. Persistent light reaction: successful treatment with cyclosporin A. Acta Derm Venereol 1988;68:176-8.